“has the potential to address safety and dosing limitations of another recently approved drug for breast cancer,”

Jeet Mukherjee · said date not stated · reported 2026-10-24

Jeet Mukherjee says Faeth Therapeutics' two-drug regimen could address safety and dosing limitations of a recently approved breast cancer drug.